Application 201272
- Type
- ANDA
- Sponsor
- INTELLIPHARMACEUTICS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 37.5MG BASE | No | No |
| 002 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 75MG BASE | No | No |
| 003 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 150MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 35208-011 | Venlafaxine Hydrochloride | Venlafaxine Hydrochloride | IntelliPharmaCeutics Corp. | ANDA | Current |
| 35208-012 | Venlafaxine Hydrochloride | Venlafaxine Hydrochloride | IntelliPharmaCeutics Corp. | ANDA | Current |
| 35208-013 | Venlafaxine Hydrochloride | Venlafaxine Hydrochloride | IntelliPharmaCeutics Corp. | ANDA | Current |